TerminatedEarly Phase 1NCT03159936

Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)

Studying Discoid lupus erythematosus

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Tufts Medical Center
Principal Investigator: David Rosmarin, MD, MD
Tufts Medical Center
Intervention: Tofacitinib citrate(biological)
Enrollment: 5 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2017 – 2020

Study locations (1)

Tufts Medical Center, Boston, Massachusetts, United States

Collaborators

Pfizer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03159936 on ClinicalTrials.gov

Other trials for Discoid lupus erythematosus

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT06261021
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus
Innovaderm Research Inc.

See all trials for Discoid lupus erythematosus →

← Back to all trials